GR1007628B - Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου - Google Patents
Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτουInfo
- Publication number
- GR1007628B GR1007628B GR20110100444A GR20110100444A GR1007628B GR 1007628 B GR1007628 B GR 1007628B GR 20110100444 A GR20110100444 A GR 20110100444A GR 20110100444 A GR20110100444 A GR 20110100444A GR 1007628 B GR1007628 B GR 1007628B
- Authority
- GR
- Greece
- Prior art keywords
- preparation
- pharmaceutical composition
- antimuscarinic agent
- composition containing
- coating layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Abstract
Η παρούσα εφεύρεση αφορά αφενός φαρμακοτεχνική σύνθεση τροποποιημένης αποδέσμευσης για χορήγηση διά στόματος, η οποία περιέχει ως δραστική ουσία ποσότητα ενός αντιμουσκαρινικού παράγοντα όπως η Τολτεροδίνη ή κάποιο φαρμακευτικά αποδεκτό άλας, παράγωγο, προφάρμακο ή μεταβολίτη αυτής, που εσωκλείεται στον πυρήνα μιας μήτρας, ο οποίος πυρήνας επικαλύπτεται με μια πρώτη στρώση ενός υδρόφοβου πολυμερούς και μια δεύτερη στρώση ενός πολυμερούς ανθεκτικού στο γαστρικό ρΗ και αφετέρου τη μέθοδο παρασκευής αυτής της σύνθεσης.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20110100444A GR1007628B (el) | 2011-07-27 | 2011-07-27 | Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου |
PL12751445T PL2736496T3 (pl) | 2011-07-27 | 2012-07-20 | Kompozycja farmaceutyczna zawierająca środek przeciwmuskarynowy i sposób jej wytwarzania |
PCT/EP2012/003076 WO2013013798A1 (en) | 2011-07-27 | 2012-07-20 | Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof |
EP12751445.3A EP2736496B1 (en) | 2011-07-27 | 2012-07-20 | Pharmaceutical composition containing an antimuscarinic agent and method for the preparation thereof |
DK12751445.3T DK2736496T3 (en) | 2011-07-27 | 2012-07-20 | PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-MUSCARINE AND PROCEDURE FOR PREPARING THEREOF |
ES12751445T ES2697609T3 (es) | 2011-07-27 | 2012-07-20 | Composición farmacéutica que contiene un agente antimuscarínico y método para la preparación del mismo |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20110100444A GR1007628B (el) | 2011-07-27 | 2011-07-27 | Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1007628B true GR1007628B (el) | 2012-06-29 |
Family
ID=45814524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20110100444A GR1007628B (el) | 2011-07-27 | 2011-07-27 | Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2736496B1 (el) |
DK (1) | DK2736496T3 (el) |
ES (1) | ES2697609T3 (el) |
GR (1) | GR1007628B (el) |
PL (1) | PL2736496T3 (el) |
WO (1) | WO2013013798A1 (el) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2013MU02631A (el) * | 2013-08-12 | 2015-06-19 | Genepharm India Pvt Ltd |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1731142A1 (en) * | 2005-06-08 | 2006-12-13 | Dexcel Pharma Technologies Ltd. | Specific time-delayed burst profile delivery system |
EP1810668A1 (en) * | 2006-01-23 | 2007-07-25 | LEK Pharmaceuticals D.D. | Coated formulations containing tolterodine tartrate |
US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
WO2010096820A1 (en) * | 2009-02-23 | 2010-08-26 | Eurand, Inc. | Controlled release compositions comprising anti-cholinergic drugs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9803871D0 (sv) | 1998-11-11 | 1998-11-11 | Pharmacia & Upjohn Ab | Therapeutic method and formulation |
WO2005105036A1 (en) * | 2004-04-28 | 2005-11-10 | Natco Pharma Limited | Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation |
WO2007029087A2 (en) | 2005-09-05 | 2007-03-15 | Ranbaxy Laboratories Limited | Controlled release multiple unit formulations |
WO2007122015A1 (en) | 2006-04-21 | 2007-11-01 | Synthon B.V. | Tolterodine beads |
-
2011
- 2011-07-27 GR GR20110100444A patent/GR1007628B/el not_active IP Right Cessation
-
2012
- 2012-07-20 DK DK12751445.3T patent/DK2736496T3/en active
- 2012-07-20 EP EP12751445.3A patent/EP2736496B1/en active Active
- 2012-07-20 WO PCT/EP2012/003076 patent/WO2013013798A1/en active Application Filing
- 2012-07-20 PL PL12751445T patent/PL2736496T3/pl unknown
- 2012-07-20 ES ES12751445T patent/ES2697609T3/es active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1731142A1 (en) * | 2005-06-08 | 2006-12-13 | Dexcel Pharma Technologies Ltd. | Specific time-delayed burst profile delivery system |
EP1810668A1 (en) * | 2006-01-23 | 2007-07-25 | LEK Pharmaceuticals D.D. | Coated formulations containing tolterodine tartrate |
US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
WO2010096820A1 (en) * | 2009-02-23 | 2010-08-26 | Eurand, Inc. | Controlled release compositions comprising anti-cholinergic drugs |
Also Published As
Publication number | Publication date |
---|---|
PL2736496T3 (pl) | 2019-02-28 |
ES2697609T3 (es) | 2019-01-25 |
EP2736496A1 (en) | 2014-06-04 |
EP2736496B1 (en) | 2018-09-05 |
DK2736496T3 (en) | 2019-01-07 |
WO2013013798A1 (en) | 2013-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201391483A1 (ru) | Фармацевтическая композиция | |
HK1211491A1 (en) | Ph-dependent controlled release pharmaceutical composition for non- opioids with resistance against the influence of ethanol ph | |
CL2014002283A1 (es) | Forma de dosificacion oral solida de liberacion inmediata que comprende particulas que comprenden un nucleo con un primer agente activo, un recubrimiento con un segundo agente activo sobre el y un material sensible al ph acido sobre dicho nucleo recubierto; proceso para prepararla; metodo de tratamiento; y uso para tratar dolor. | |
WO2012021629A3 (en) | Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease | |
BR112014003802A2 (pt) | composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento | |
BRPI0823096A2 (pt) | Composição de opioide farmacêutica de liberação controlada, dependente do ph, com resistência contra a influência do etanol | |
BRPI0818680A2 (pt) | composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica | |
WO2011106416A3 (en) | Abuse-resistant formulations | |
BRPI1007725A2 (pt) | composição de revestimento de liberação imediata com propriedades melhoradas de barreira à umidade, suspensão aquosa, substrato oral revestido, forma de dosagem oral e método para preparação da mesma | |
CL2012002909A1 (es) | Procedimiento de preparación de una composición farmacéutica que comprenden a) un centro granulado constituido por granos de principio activo aglomerados en presencia de aglomerante y b) una capa de recubrimiento de dicho centro granulado constituido por matriz grasa; composición farmacéutica; y su uso para administración oral | |
MX360389B (es) | Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico. | |
WO2013009142A3 (en) | Sustained/release pharmaceutical composition comripising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same | |
EP2666773A8 (en) | Organic amine salts of azilsartan, preparation method and use thereof | |
EP2716640A4 (en) | [HEXAHYDRODIBENZO- [A, G-] CHINOLICINE COMPOUND, PROCESS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION THEREFOR AND THEIR USE | |
WO2011140446A3 (en) | Pharmaceutical formulations | |
PL3067353T3 (pl) | Sposób wytwarzania soli solifenacyny i ich włączenie do farmaceutycznych postaci dawkowania | |
WO2013017910A8 (en) | Extended release pharmaceutical compositions containing paliperidone | |
WO2013083826A3 (en) | Glp-1 agonists | |
SI2612681T1 (sl) | Obložno sredstvo za farmacevtsko trdno obliko, farmacevtska filmska formulacija in obložena farmacevtska trdna oblika | |
EP2759547A4 (en) | PLATIN CONNECTION WITH AMINO OR ALKYLAMINE-CONTAINING AMMONIC ACID DERIVATIVES AS A SUBSTITUTE GROUP, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF | |
GR1007628B (el) | Φαρμακευτικο σκευασμα περιεχον εναν αντιμουσκαρινικο παραγοντα και μεθοδος για την παρασκευη αυτου | |
WO2014181195A3 (en) | Antiemetic extended release solid dosage forms | |
BR112013007904A2 (pt) | "composto, composição farmacêutica, medicamento, uso de um composto e proceso para preparar um composto" | |
WO2012014052A3 (en) | Novel coated extended release pharmaceutical compositions containing paliperidone | |
EP2562156A4 (en) | DERIVATIVES OF COLCHICINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PROCESS FOR THE PREPARATION OF SAID DERIVATIVES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAID DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted |
Effective date: 20120713 |
|
ML | Lapse due to non-payment of fees |
Effective date: 20170207 |